PMID: 9426760Jan 14, 1998Paper

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis

Urology
R A Appell

Abstract

To examine the safety, efficacy, and tolerability of tolterodine in four randomized, double-blind, parallel, multicenter, 12-week studies of patients with overactive bladder. Two of the four studies compared tolterodine (2 mg twice daily) to oxybutynin (5 mg three times daily) and placebo, one study compared tolterodine (2 mg twice daily) to oxybutynin (5 mg three times daily), and one study compared two dosages of tolterodine (1 and 2 mg twice daily) to placebo. Efficacy was determined from micturition diaries and patient perception of their bladder condition. Safety and tolerability were assessed from adverse events and laboratory measures. A total of 1,120 patients were randomized and treated at 134 centers. For the primary efficacy variable, the number of micturitions/24 hours, pooled results showed a significant decrease from baseline for the 1 mg tolterodine (P < 0.001), 2 mg tolterodine (P < 0.001), and 5 mg oxybutynin (P < 0.01) groups, compared to placebo. Both tolterodine doses and oxybutynin significantly decreased incontinence episodes/24 hours and significantly increased volume voided/micturition, compared to placebo. Tolterodine at a dose of 2 mg twice daily and 5 mg oxybutynin twice daily were significantly more ...Continue Reading

Citations

Jul 7, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Simon HillUNKNOWN Darifenacin Study Group
Jan 26, 2012·International Urogynecology Journal·Linda BrubakerKarl-Dietrich Sievert
Sep 6, 2005·International Urology and Nephrology·Robert B ArmstrongKenneth M Peters
Jul 27, 2006·International Urology and Nephrology·Dionisios MitropoulosAris Giannopoulos
Jun 27, 2002·Current Urology Reports·E S Rovner
Oct 2, 2002·Current Urology Reports·H Henry LaiRodney A Appell
Nov 19, 2003·Current Urology Reports·Scott A MacDiarmid
Nov 16, 2004·Current Urology Reports·Helmut G Madersbacher
Oct 22, 2005·Current Urology Reports·Roger Dmochowski, David R Staskin
Oct 25, 2008·Current Urology Reports·Scott MacDiarmidBimal K Malhotra
Jul 9, 2002·Obstetrics and Gynecology·Leslee L SubakKrikor Soghikian
Sep 10, 2003·Obstetrics and Gynecology·Robert FreemanUNKNOWN Tolterodine Study Group
Dec 15, 2000·Urology·R R Dmochowski, R A Appell
Mar 15, 2001·Urology·P Van KerrebroeckUNKNOWN Tolterodine Study Group
Dec 21, 2002·Urology·Christopher R ChappleRussell Chess-Williams
Jul 24, 2003·European Urology·Thomas LeippoldBrigitte Schurch
Feb 14, 2002·Australian Family Physician
Sep 6, 2000·Journal of Clinical Pharmacy and Therapeutics·P K Sarkar, A E Ritch
Jun 13, 2002·International Journal of Urology : Official Journal of the Japanese Urological Association·Jeong Gu LeeTack Lee
Apr 12, 2001·BJU International·K HjälmåsA Stenberg
Mar 5, 2003·BJU International·A MattiassonUNKNOWN Tolterodine Scandinavian Study Group
Jul 17, 2001·Journal of the American Geriatrics Society·J G Malone-LeeM F Maugourd
Jul 17, 2001·Journal of the American Geriatrics Society·C E DuBeau
May 25, 2002·Journal of the American Geriatrics Society·Philip S WangJerry Avorn
Jul 12, 2002·Journal of the American Geriatrics Society·Philip D SloaneJoan F Walsh
Nov 13, 2001·Journal of Women's Health & Gender-based Medicine·C Crandall
Nov 13, 2001·Journal of Women's Health & Gender-based Medicine·C TannenbaumG A Kuchel
Nov 18, 1998·Current Opinion in Obstetrics & Gynecology·V Khullar, L Cardozo
Feb 15, 2001·The Journal of Urology·S P Marinkovic, G Badlani
Nov 25, 2000·BMJ : British Medical Journal·R Thakar, S Stanton
Jul 11, 2007·Postgraduate Medical Journal·Sushma SrikrishnaMaria Vella
Jan 12, 2008·The American Journal of Chinese Medicine·Sang Pil YunHyung Sup Bae

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.